跳至主要内容
临床试验/ISRCTN23705289
ISRCTN23705289进行中(未招募)未知

A feasibility study to investigate the acceptability of 99m Tc SestaMIBI SPECT/CT for kidney mass characterisation

niversity College London0 个研究点目标入组 50 人开始时间: 2021年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Adult patients >18 years of age and less than 95 years
  • 2. Renal tumour >2 cm identified on cross sectional imaging (CT or MRI)
  • 3. Patients undergoing tumour biopsy, surgery or who have previously had a biopsy and are on active surveillance programmes
  • 4. Capacity to provide informed consent

排除标准

  • 1. Females who are pregnant, planning pregnancy or breastfeeding
  • 2. Concurrent and/or recent involvement in other research that is likely to interfere with the intervention within 3 months of study enrolment
  • 3. Multiple comorbidities which would make trial participation difficult (e.g. burden of an additional hospital visit)
  • 4. Allergy to 99m Tc-sestamibi

研究者

发起方
niversity College London

相似试验

Can a nuclear medicine scan (MIBI) detect whether a... | 临床试验